Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (5): 745-746    DOI: 10.12891/ceog4218.2018
Original Research Previous articles | Next articles
The impact of oral contraception with ethinyl estradiol and chlormadinone acetate on sexual function of women
G. Jarząbek-Bielecka1, R. Słopień2, *(), A. Słopień 3, M. Pisarska-Krawczyk4, 6, W. Kędzia11, M. Wilczak4, 5
1 Unit of Developmental Age Gynecology and Sexology, Division of Gynecology, Department of Perinatology and Gynecology, Poznań University of Medical Sciences, Poznań, Poland
2 Department of Gynecological Endocrinology, Poznań University of Medical Sciences, Poznań, Poland
3 Department of Child and Adolescent Psychiatry, Poznań University of Medical Sciences, Poznań, Poland
4 Department of Maternal and Child Health, Poznań University of Medical Sciences, Poznań, Poland
5 Department of Medical Education, Poznań University of Medical Sciences, Poznań, Poland
6 President Stanisław Wojciechowski Vocational State School, Kalisz, Poland
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Hormonal contraception influences various areas of female health and behavior. The study group included 41 women aged 18-25 (mean age 22.2 ± 3.4) years who used oral contraception with 3 mg of ethinyl estradiol and 2 mg of chlormadinone acetate for six months. The mean body mass index (BMI) of women from the study group was 23. 5 ± 2.3 kg/m2 . The exclusion criteria from the study group where contraindications for hormonal contraception (liver disease, porphyria, thrombosis, hormonally dependent cancer, and migraine). The control group included 31 women aged 18-25 (mean age 21.6 ± 2.4) years who did not use hormonal contraception. The mean BMI of controls was 22.4 ± 1.7 kg/m2. Both the age and the BMI of controls were no statistically different from the study group. The sexual function of the studied women was assessed with the use of Female Sexual Function Index (FSFI). FSFI is a multidimensional self-reporting tool for the assessment of female sexual function. It consists of six domains: desire, arousal, lubrication, orgasm, satisfaction, and pain (with 19 items). There were no statistically relevant differences between the study group and the controls in relations to the FSFI parameters. There is no impact of oral contraception with 3 mg of ethinyl estradiol and 2 mg of chlormadinone acetate on sexual function of users.
Key words:  Contraception      Sexual function      Desire     
Published:  10 October 2018     
*Corresponding Author(s):  R. SŁOPIEŃ     E-mail:  asrs@wp.pl

Cite this article: 

G. Jarząbek-Bielecka, R. Słopień, A. Słopień, M. Pisarska-Krawczyk, W. Kędzia, M. Wilczak. The impact of oral contraception with ethinyl estradiol and chlormadinone acetate on sexual function of women. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 745-746.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4218.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I5/745

[1] S. Nayak, A. Avery, J. McLeod Griffiss, C.D. Charles, K.R. Culwell. A randomized placebo-controlled pilot study of the effect and duration of Amphora, a multipurpose vaginal pH regulator, on vaginal pH[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 736-742.
[2] J. Chan Hee, K. Jae Won, L. Jae Kwan, S. Seung Hun. Psychological epidemiology of sexual function change after conization for cervical dysplasia[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 76-80.
[3] O. Birge, D. Arslan, E.G. Ozbey, M. Adiyeke, I. Kayar, M.M. Erkan, U. Akgör. Which type of circumcision is more harmful to female sexual functions?[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 691-694.
[4] F. Nobili, A. Lukic, I. Puccica, M. Vitali, M. Schimberni, F. Manzara, A. Frega, B. Mossa, M. Moscarini, D. Caserta. The relevance of fascial surgical repair in the management of pelvic organ prolapse (POP)[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 744-748.
No Suggested Reading articles found!